oseltamivir has been researched along with pd 184352 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ehrhardt, C; Haasbach, E; Ludwig, S; Müller, C; Planz, O; Pleschka, S; Schreiber, A | 1 |
1 other study(ies) available for oseltamivir and pd 184352
Article | Year |
---|---|
The MEK-inhibitor CI-1040 displays a broad anti-influenza virus activity in vitro and provides a prolonged treatment window compared to standard of care in vivo.
Topics: A549 Cells; Animals; Antiviral Agents; Benzamides; Disease Models, Animal; Drug Resistance, Viral; Humans; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Lung; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Orthomyxoviridae; Oseltamivir; Standard of Care; Viral Load | 2017 |